These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22321383)

  • 1. N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy.
    Guan M; Zhou Y; Zhu QL; Liu Y; Bei YY; Zhang XN; Zhang Q
    Nanomedicine; 2012 Oct; 8(7):1172-81. PubMed ID: 22321383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers.
    Guan M; Zhu QL; Liu Y; Bei YY; Gu ZL; Zhang XN; Zhang Q
    Int J Nanomedicine; 2012; 7():1921-30. PubMed ID: 22605938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
    Wang Q; Zhang L; Hu W; Hu ZH; Bei YY; Xu JY; Wang WJ; Zhang XN; Zhang Q
    Nanomedicine; 2010 Apr; 6(2):371-81. PubMed ID: 19699319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-targeted delivery using ph-sensitive liposomes loaded with lactosylnorcantharidin phospholipid complex: preparation, characterization, and therapeutic evaluation in vivo and in vitro.
    Qiao-ling Z; Yi Z; Min G; Di-jia Y; Xiao-feng Z; Yang L; Jing-yu X; Ying W; Zong-lin G; Kong-lang X; Ai-jun Z; Wei-liang C; Lin-sen S; Xue-nong Z; Qiang Z
    Curr Med Chem; 2012; 19(33):5754-63. PubMed ID: 22963621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS.
    Ding XY; Hong CJ; Liu Y; Gu ZL; Xing KL; Zhu AJ; Chen WL; Shi LS; Zhang XN; Zhang Q
    Int J Nanomedicine; 2012; 7():1723-35. PubMed ID: 22619523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption.
    Bei YY; Chen XY; Liu Y; Xu JY; Wang WJ; Gu ZL; Xing KL; Zhu AJ; Chen WL; Shi LS; Wang Q; Zhang XN; Zhang Q
    Int J Nanomedicine; 2012; 7():1819-27. PubMed ID: 22619530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary in vitro and in vivo evaluation of norcantharidin-chitosan/poly (vinyl alcohol) for cancer treatment.
    Li M; Xu X; Lu F; Guo S
    Drug Deliv; 2014 Jun; 21(4):293-301. PubMed ID: 24156408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising positive liver targeting delivery system based on arabinogalactan-anchored polymeric micelles of norcantharidin.
    Zhang Z; Yang L; Hou J; Xia X; Wang J; Ning Q; Jiang S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S630-S640. PubMed ID: 30449176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vivo anti-tumor activity of a novel poloxamer-based thermosensitive in situ gel for sustained delivery of norcantharidin.
    Xie MH; Ge M; Peng JB; Jiang XR; Wang DS; Ji LQ; Ying Y; Wang Z
    Pharm Dev Technol; 2019 Jun; 24(5):623-629. PubMed ID: 30457414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
    Liang L; Zhao L; Wang Y; Wang Y
    Mol Pharm; 2021 Mar; 18(3):1003-1013. PubMed ID: 33527831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
    Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
    Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma.
    Jiang S; Li M; Hu Y; Zhang Z; Lv H
    Carbohydr Polym; 2018 Oct; 197():194-203. PubMed ID: 30007605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on anti-hepatocarcinoma effect, pharmacokinetics and tissue distribution of carboxymethyl chitosan based norcantharidin conjugates.
    Chi J; Jiang Z; Chen X; Peng Y; Liu W; Han B; Han B
    Carbohydr Polym; 2019 Dec; 226():115297. PubMed ID: 31582090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro and in vivo evaluation of new norcantharidin-conjugated hydroxypropyltrimethyl ammonium chloride chitosan derivatives as polymer therapeutics.
    Xu X; Li Y; Wang F; Lv L; Liu J; Li M; Guo A; Jiang J; Shen Y; Guo S
    Int J Pharm; 2013 Sep; 453(2):610-9. PubMed ID: 23742972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.
    Ren J; Li G; Zhao W; Lin L; Ye T
    World J Gastroenterol; 2016 Apr; 22(15):3962-8. PubMed ID: 27099439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma.
    Jiang Z; Chi J; Han B; Liu W
    Carbohydr Polym; 2017 Oct; 174():282-290. PubMed ID: 28821069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro cellular evaluation of novel anti-tumor norcantharidin-conjugated chitosan derivatives.
    Xu X; Li Y; Shen Y; Guo S
    Int J Biol Macromol; 2013 Nov; 62():418-25. PubMed ID: 24099934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycyrrhetinic Acid-Modified Norcantharidin Nanoparticles for Active Targeted Therapy of Hepatocellular Carcinoma.
    Zhang H; Jiang Y; Ni X; Chen L; Wu M; Liu J; Yang B; Shan X; Yang L; Fan J; Chen Y; Wu J; Fu S
    J Biomed Nanotechnol; 2018 Jan; 14(1):114-126. PubMed ID: 29463369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis.
    Yan Z; Yang K; Tang X; Bi Y; Ding Y; Deng M; Xia D; Zhao Y; Chen T
    J Immunol Res; 2022; 2022():3851604. PubMed ID: 35497873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.